London · Delayed Price · Currency is GBP · Price in EUR GenSight Biologics Statistics
Total Valuation
LON:0RIM has a market cap or net worth of GBP 15.75 million. The enterprise value is 32.08 million.
| Market Cap | 15.75M |
| Enterprise Value | 32.08M |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 220.49M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +77.81% |
| Shares Change (QoQ) | +17.94% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 10.76% |
| Float | 145.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.44 |
| PB Ratio | -0.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.48 |
| EV / Sales | 38.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -165.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -85.07% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 83.20% |
| Weighted Average Cost of Capital (WACC) | 4.28% |
| Revenue Per Employee | 62,311 |
| Profits Per Employee | -996,982 |
| Employee Count | 13 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LON:0RIM has paid 6,000 in taxes.
| Income Tax | 6,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.04% in the last 52 weeks. The beta is 0.74, so LON:0RIM's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -74.04% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.15 |
| Relative Strength Index (RSI) | 39.05 |
| Average Volume (20 Days) | 31,409 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0RIM had revenue of GBP 810,048 and -12.96 million in losses. Loss per share was -0.11.
| Revenue | 810,048 |
| Gross Profit | 810,048 |
| Operating Income | -13.03M |
| Pretax Income | -12.95M |
| Net Income | -12.96M |
| EBITDA | -13.32M |
| EBIT | -13.03M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 231,442 in cash and 16.30 million in debt, with a net cash position of -16.07 million.
| Cash & Cash Equivalents | 231,442 |
| Total Debt | 16.30M |
| Net Cash | -16.07M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -27.52M |
| Book Value Per Share | -0.21 |
| Working Capital | -19.64M |
Cash Flow
| Operating Cash Flow | -6.90M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,608.57% |
| Pretax Margin | -1,599.26% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LON:0RIM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -77.81% |
| Shareholder Yield | -77.81% |
| Earnings Yield | -82.29% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0RIM has an Altman Z-Score of -11.25 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.25 |
| Piotroski F-Score | 2 |